OBESE RX

WELCOME TO OBESERX.COM

OBESERX.COM is obesity-care English: Obese Rx—pharmacies and metabolic clinics that already say “Obese Rx” when they mean obesity-medication education funnels, not NSAID class twins.

Best-fit buyers: obesity-care clinics; specialty pharmacies; telehealth metabolic desks; defensive holders. Exact-fit launch: an Obese Rx hub with therapy tiles, eligibility FAQ, and clinician disclaimer.

CDC NCHS reported 40.3% of U.S. adults age 20+ had obesity during August 2021–August 2023 (NHANES)—the prevalence spine behind obesity-care Rx brandables.^[1] ASHP projected U.S. prescription drug spending at $915.2 billion in 2025—the Rx-spend bench metabolic therapies already sit inside.^[2] That prevalence × Rx spine frames why exact Obese Rx inventory matters—not an invented category TAM.

Why Choose OBESERX.COM

• 💊 Obese Rx lockup: Obesity-care pharmacy English already spoken.
• 📊 Prevalence spine: 40.3% adult obesity (CDC NHANES).^[1]
• 💵 Rx bench: $915.2B U.S. Rx spend (2025).^[2]
• 🔍 Vs NSAIDRx: Obesity care ≠ NSAID class education.
• ⚠️ Clinical-first: Buyer owns indications, REMS, and claims.
• ✨ Clinic clarity: Sounds like the hostname on a metabolic funnel.

WHAT DOES ALAN ISAACS THINK?

"obeserx.com is obesity-care inventory—Obese Rx, not NSAIDRx."

Alan Isaacs, Finance Manager

Contact Alan Isaacs via Email